Amirol, Ebpao C.
HRN: 23-87-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
CEFTAZIDIME 1GM (VIAL)
12/09/2025
12/16/2025
IV
2g
Q8h
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes